Noncardiovascular morbidity and mortality across left ventricular ejection fraction categories following hospitalization for heart failure-Reference-Cited by-同舟云学术

Noncardiovascular morbidity and mortality across left ventricular ejection fraction categories following hospitalization for heart failure

Published:2023-06 Issue: Volume: Page:
ISSN:1885-5857
Container-title:Revista Española de Cardiología (English Edition)
language:en
Short-container-title:Revista Española de Cardiología (English Edition)

Author:

Santas Enrique,Llácer Pau,Palau Patricia,de la Espriella Rafael,Miñana Gema,Lorenzo Miguel,Núñez-Marín Gonzalo,Miró Òscar,Chorro Francisco Javier,Bayés-Genís Antoni,Sanchis Juan,Núñez Julio

Publisher

Elsevier BV

Subject

General Medicine

Reference35 articles.

1. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association of the ESC;McDonagh;Rev Esp Cardiol.,2022

2. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure

3. Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure;Chun;Circ Heart Fail.,2012

4. Burden of Recurrent Hospitalizations Following an Admission for Acute Heart Failure: Preserved Versus Reduced Ejection Fraction;Santas;Rev Esp Cardiol.,2017

5. effect of candesartan on cause specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program;Solomon;Circulation.,2004

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidencia, predictores e impacto pronóstico de una clase funcional disminuida inmediatamente después de un implante percutáneo de válvula aórtica;Revista Española de Cardiología;2024-05

2. N‐terminal pro‐B‐type natriuretic peptide post‐discharge monitoring in the management of patients with heart failure and preserved ejection fraction – a randomized trial: The NICE study;European Journal of Heart Failure;2024-04